MK-677: adverse events and evidence limits
A one-year oral MK-677 analysis in healthy adults aged 60–81 described increased appetite, mild transient leg edema and muscle pain. Fasting glucose rose and insulin sensitivity declined. [1]
These findings concern the studied tablets and cohort. [1]
What the studies reported
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Increased appetite | Healthy adults aged 60–81, oral MK-677, one-year analysis | Described; no percentage given in the abstract | [1] |
| Mild transient leg edema | The same participants | Described as mild and transient; no frequency given | [1] |
| Muscle pain | The same participants | Described; no frequency given | [1] |
| Fasting glucose rise and reduced insulin sensitivity | The same participants | Observed; metabolic measurements, no percentage given | [1] |
References
- Ralf Nass et al. (2008). Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial https://doi.org/10.7326/0003-4819-149-9-200811040-00003.